{"id":9257,"date":"2024-01-18T20:10:14","date_gmt":"2024-01-18T17:10:14","guid":{"rendered":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"modified":"2024-01-18T20:10:14","modified_gmt":"2024-01-18T17:10:14","slug":"matibabu-ya-urejeshi-kulingana-na-teknolojia-ya-neva-hutoa-mbadala-salama-kwa-dawa-kwa-wagonjwa-wa-kiharusi-na-ms","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/sw\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","title":{"rendered":"Tiba ya RecoveriX inayotegemea Neurotechnology Hutoa Dawa Mbadala Salama kwa Wagonjwa wa Kiharusi na MS."},"content":{"rendered":"
<\/div>\n

Huku watu wengi wakiugua magonjwa ya mfumo wa neva kama vile kiharusi na sclerosis nyingi (MS) kila mwaka, ufahamu wa hali hizi na jinsi ya kutibu au kudhibiti umekuwa muhimu zaidi. Kulingana na Shirika la Afya Duniani, hatari ya maisha ya kupata kiharusi ina iliongezeka kwa 50% katika kipindi cha miaka 17 iliyopita<\/span><\/a>, huku karibu mtu mmoja kati ya kila watu wanne akitarajiwa kuugua kiharusi katika maisha yao. Wakati huo huo, karibu watu milioni 3 <\/span><\/a>kuwa na MS duniani kote.<\/p>\n

Wagonjwa wa kiharusi na MS mara nyingi huachwa na ubora uliopungua wa maisha, kwa sababu ya harakati ndogo na uhamaji wa misuli, haswa katika viungo vyao. Dawa nyingi zinazotolewa kwa wagonjwa haziwezi kurejesha utendaji wa mwili ulioathiriwa. Badala yake, hizi zinaweza tu kuzuia hali ya mgonjwa kutoka kuzorota au, katika kesi ya MS, kupunguza kasi ya mgonjwa kupungua. Dawa za antispastic za mdomo mara nyingi hutoa athari ndogo na inaweza kusababisha madhara<\/span><\/a> kama vile udhaifu, kuchanganyikiwa na kizunguzungu. Kwa wagonjwa wengine, dozi ndogo za sumu ya botulinum (botox) hudungwa kwenye misuli ili kupunguza mshtuko. Matibabu haya yanafaa kwa karibu wiki 12 tu, kabla ya haja ya kurudiwa, ambayo inaweza kuwa ya gharama kubwa na hatari.<\/p>\n

Tofauti na dawa nyingi za kiharusi na MS kwenye soko, kurejeshaX<\/span><\/a>, matibabu ya urekebishaji wa kiolesura cha ubongo-kompyuta, imeonyeshwa kusaidia katika urekebishaji wa kiharusi<\/span><\/a> na sclerosis nyingi<\/span><\/a> wagonjwa. Imetengenezwa na kampuni yenye makao yake Austria g.tec uhandisi wa matibabu<\/span><\/a>, recoveriX kwa umeme huchangamsha viungo vya wagonjwa, huwasaidia kurejesha utendaji wao baada ya kuathiriwa na hali ya neva. Mgonjwa anakaa mbele ya kitengo cha kompyuta huku akiwa amevaa kifaa cha EEG kinachosoma mawimbi ya ubongo ya mgonjwa. Mfuatiliaji hutumika kama mwongozo wa harakati kwa viungo vyao na elektroni zilizounganishwa na miguu yao hutoa msukumo wa umeme kwa misuli, na kusababisha dorsiflexion ya viungo. Kila kipindi cha matibabu hudumu kwa takriban saa moja, na kizuizi kimoja cha matibabu cha recoveriX kinachojumuisha vikao 25, haswa mara tatu kwa wiki.<\/p>\n

Matumizi ya mara kwa mara ya recoveriX <\/span><\/a>imeonyeshwa kusaidia wagonjwa kurejesha matumizi ya viungo vyao, kwa kupungua kwa spasticity na ujuzi bora wa magari. Kwa mfano, hii inaweza kuwa iliyoonyeshwa<\/span><\/a> kwa utendakazi bora katika jaribio la kigingi cha mashimo tisa, kipimo cha ustadi mzuri wa mwongozo. Wagonjwa pia wameonyesha umakini mzuri, utendaji wa mwili, utambuzi, kumbukumbu na udhibiti wa kibofu. Hizi huchangia kuboresha maisha na kuruhusu wagonjwa kufanya shughuli nyingi ambazo hawakuweza kufanya baada ya kupata kiharusi au MS.<\/p>\n

Kulingana na mwanzilishi na Mkurugenzi Mtendaji wa g.tec, Dk. Christoph Guger, recoveriX, ambayo inategemea uhamasishaji wa kuona na misuli ya kielektroniki ina athari nyingi chanya bila athari mbaya yoyote. Anaongeza kuwa kwa kuangalia tafiti za kimatibabu kwa ajili ya dawa, kuna haja ya maelfu ya wagonjwa kuthibitisha kuwa dawa hiyo ina athari fulani. Kwa sababu jaribio la kimatibabu linahusisha kupima idadi kubwa ya watu, hii haimaanishi kuwa dawa ni bora kwa mgonjwa binafsi.<\/p>\n

Zaidi ya hayo, kwa ugonjwa wa sclerosis nyingi, kuna karibu dawa 20 tofauti ambazo zinaweza kutumika, kulingana na mgonjwa na aina ya MS. Baada ya mwaka mmoja wa kuchukua dawa fulani, mgonjwa anatathminiwa ikiwa ni bora. Ikiwa dawa sio sahihi kwa mgonjwa, kuna nafasi kwamba inaweza kufanya mambo kuwa mabaya zaidi, Guger anasema.<\/p>\n

Licha ya athari kubwa chanya ya matibabu mapya, yanayowezeshwa na teknolojia kama vile recoveriX, Guger anabainisha kuwa wakati fulani madaktari wanaweza kusitasita kuwaagiza. Baadhi ya makampuni ya bima, vilevile, bado hayajashughulikia matibabu haya. Kulingana na Guger, hii ni kwa sababu madaktari wengi walifunzwa pekee kuhusu dawa na recoveryiX bado haikuwepo walipokuwa katika shule ya matibabu. Hata hivyo, baada ya muda, anaamini kwamba wataalamu zaidi wa matibabu wataona manufaa ya recoveriX na kuchanganya na dawa zao na regimens za matibabu. Zaidi ya hayo, kampuni za bima zitaanza kushughulikia vipindi vya recoveryiX mara tu zitakapoona data ambayo inafanya kazi na kusababisha gharama ya chini ya malipo ya bima.<\/p>\n

Leo, recoveriX inapatikana katika nchi nyingi barani Ulaya, Asia-Pasifiki, Amerika Kaskazini na Afrika na g.tec inatumia mfumo wa kipekee wa franchise kuwezesha kuenea kwa haraka kwa teknolojia. Guger anapambana ili kuhakikisha kwamba watu wengi zaidi wanaougua kiharusi, MS na magonjwa mengine ya neva wataweza kufikia recoveriX na kujionea madhara yake chanya, na pia kueneza habari kwa watu wengine wanaohitaji.<\/p>\n

Chanzo cha matibabu cha kila siku<\/a><\/p>\n

","protected":false},"excerpt":{"rendered":"

<\/div>\n

Huku watu wengi wakiugua magonjwa ya mfumo wa neva kama vile kiharusi na sclerosis nyingi (MS) kila mwaka, ufahamu wa hali hizi na jinsi ya kutibu au kudhibiti umekuwa muhimu zaidi. Kulingana na Shirika la Afya Duniani, hatari ya maisha ya kupata kiharusi ina iliongezeka kwa 50% katika kipindi cha miaka 17 iliyopita<\/span><\/a>, huku karibu mtu mmoja kati ya kila watu wanne akitarajiwa kuugua kiharusi katika maisha yao. Wakati huo huo, karibu watu milioni 3 <\/span><\/a>kuwa na MS duniani kote.<\/p>\n

Wagonjwa wa kiharusi na MS mara nyingi huachwa na ubora uliopungua wa maisha, kwa sababu ya harakati ndogo na uhamaji wa misuli, haswa katika viungo vyao. Dawa nyingi zinazotolewa kwa wagonjwa haziwezi kurejesha utendaji wa mwili ulioathiriwa. Badala yake, hizi zinaweza tu kuzuia hali ya mgonjwa kutoka kuzorota au, katika kesi ya MS, kupunguza kasi ya mgonjwa kupungua. Dawa za antispastic za mdomo mara nyingi hutoa athari ndogo na inaweza kusababisha madhara<\/span><\/a> kama vile udhaifu, kuchanganyikiwa na kizunguzungu. Kwa wagonjwa wengine, dozi ndogo za sumu ya botulinum (botox) hudungwa kwenye misuli ili kupunguza mshtuko. Matibabu haya yanafaa kwa karibu wiki 12 tu, kabla ya haja ya kurudiwa, ambayo inaweza kuwa ya gharama kubwa na hatari.<\/p>\n

Tofauti na dawa nyingi za kiharusi na MS kwenye soko, kurejeshaX<\/span><\/a>, matibabu ya urekebishaji wa kiolesura cha ubongo-kompyuta, imeonyeshwa kusaidia katika urekebishaji wa kiharusi<\/span><\/a> na sclerosis nyingi<\/span><\/a> wagonjwa. Imetengenezwa na kampuni yenye makao yake Austria g.tec uhandisi wa matibabu<\/span><\/a>, recoveriX kwa umeme huchangamsha viungo vya wagonjwa, huwasaidia kurejesha utendaji wao baada ya kuathiriwa na hali ya neva. Mgonjwa anakaa mbele ya kitengo cha kompyuta huku akiwa amevaa kifaa cha EEG kinachosoma mawimbi ya ubongo ya mgonjwa. Mfuatiliaji hutumika kama mwongozo wa harakati kwa viungo vyao na elektroni zilizounganishwa na miguu yao hutoa msukumo wa umeme kwa misuli, na kusababisha dorsiflexion ya viungo. Kila kipindi cha matibabu hudumu kwa takriban saa moja, na kizuizi kimoja cha matibabu cha recoveriX kinachojumuisha vikao 25, haswa mara tatu kwa wiki.<\/p>\n

Matumizi ya mara kwa mara ya recoveriX <\/span><\/a>imeonyeshwa kusaidia wagonjwa kurejesha matumizi ya viungo vyao, kwa kupungua kwa spasticity na ujuzi bora wa magari. Kwa mfano, hii inaweza kuwa iliyoonyeshwa<\/span><\/a> kwa utendakazi bora katika jaribio la kigingi cha mashimo tisa, kipimo cha ustadi mzuri wa mwongozo. Wagonjwa pia wameonyesha umakini mzuri, utendaji wa mwili, utambuzi, kumbukumbu na udhibiti wa kibofu. Hizi huchangia kuboresha maisha na kuruhusu wagonjwa kufanya shughuli nyingi ambazo hawakuweza kufanya baada ya kupata kiharusi au MS.<\/p>\n

Kulingana na mwanzilishi na Mkurugenzi Mtendaji wa g.tec, Dk. Christoph Guger, recoveriX, ambayo inategemea uhamasishaji wa kuona na misuli ya kielektroniki ina athari nyingi chanya bila athari mbaya yoyote. Anaongeza kuwa kwa kuangalia tafiti za kimatibabu kwa ajili ya dawa, kuna haja ya maelfu ya wagonjwa kuthibitisha kuwa dawa hiyo ina athari fulani. Kwa sababu jaribio la kimatibabu linahusisha kupima idadi kubwa ya watu, hii haimaanishi kuwa dawa ni bora kwa mgonjwa binafsi.<\/p>\n

Zaidi ya hayo, kwa ugonjwa wa sclerosis nyingi, kuna karibu dawa 20 tofauti ambazo zinaweza kutumika, kulingana na mgonjwa na aina ya MS. Baada ya mwaka mmoja wa kuchukua dawa fulani, mgonjwa anatathminiwa ikiwa ni bora. Ikiwa dawa sio sahihi kwa mgonjwa, kuna nafasi kwamba inaweza kufanya mambo kuwa mabaya zaidi, Guger anasema.<\/p>\n

Licha ya athari kubwa chanya ya matibabu mapya, yanayowezeshwa na teknolojia kama vile recoveriX, Guger anabainisha kuwa wakati fulani madaktari wanaweza kusitasita kuwaagiza. Baadhi ya makampuni ya bima, vilevile, bado hayajashughulikia matibabu haya. Kulingana na Guger, hii ni kwa sababu madaktari wengi walifunzwa pekee kuhusu dawa na recoveryiX bado haikuwepo walipokuwa katika shule ya matibabu. Hata hivyo, baada ya muda, anaamini kwamba wataalamu zaidi wa matibabu wataona manufaa ya recoveriX na kuchanganya na dawa zao na regimens za matibabu. Zaidi ya hayo, kampuni za bima zitaanza kushughulikia vipindi vya recoveryiX mara tu zitakapoona data ambayo inafanya kazi na kusababisha gharama ya chini ya malipo ya bima.<\/p>\n

Leo, recoveriX inapatikana katika nchi nyingi barani Ulaya, Asia-Pasifiki, Amerika Kaskazini na Afrika na g.tec inatumia mfumo wa kipekee wa franchise kuwezesha kuenea kwa haraka kwa teknolojia. Guger anapambana ili kuhakikisha kwamba watu wengi zaidi wanaougua kiharusi, MS na magonjwa mengine ya neva wataweza kufikia recoveriX na kujionea madhara yake chanya, na pia kueneza habari kwa watu wengine wanaohitaji.<\/p>","protected":false},"author":2,"featured_media":9258,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[],"class_list":["post-9257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nNeurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/sw\/matibabu-ya-urejeshi-kulingana-na-teknolojia-ya-neva-hutoa-mbadala-salama-kwa-dawa-kwa-wagonjwa-wa-kiharusi-na-ms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/sw\/matibabu-ya-urejeshi-kulingana-na-teknolojia-ya-neva-hutoa-mbadala-salama-kwa-dawa-kwa-wagonjwa-wa-kiharusi-na-ms\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-18T17:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"dakika 4\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"wordCount\":727,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"sw\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\"},\"inLanguage\":\"sw\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"caption\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sw\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/sw\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Matibabu ya Neurotechnology-Based RecoveriX Hutoa Dawa Mbadala Salama kwa Wagonjwa wa Kiharusi na MS - Kliniki ya Huduma ya Mjini","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/sw\/matibabu-ya-urejeshi-kulingana-na-teknolojia-ya-neva-hutoa-mbadala-salama-kwa-dawa-kwa-wagonjwa-wa-kiharusi-na-ms\/","og_locale":"en_US","og_type":"article","og_title":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic","og_description":"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.","og_url":"https:\/\/urbancare.clinic\/sw\/matibabu-ya-urejeshi-kulingana-na-teknolojia-ya-neva-hutoa-mbadala-salama-kwa-dawa-kwa-wagonjwa-wa-kiharusi-na-ms\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2024-01-18T17:10:14+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Urban Care Clinic","Est. reading time":"dakika 4"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients","datePublished":"2024-01-18T17:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"wordCount":727,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","articleSection":["Medical Daily"],"inLanguage":"sw"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","url":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","name":"Matibabu ya Neurotechnology-Based RecoveriX Hutoa Dawa Mbadala Salama kwa Wagonjwa wa Kiharusi na MS - Kliniki ya Huduma ya Mjini","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","datePublished":"2024-01-18T17:10:14+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb"},"inLanguage":"sw","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"]}]},{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","caption":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Kliniki ya Huduma ya Mjini","description":"Kliniki yako ya Afya Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sw"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Kliniki ya Huduma ya Mijini Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"Kliniki ya Huduma ya Mjini","image":{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/sw\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts\/9257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/comments?post=9257"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts\/9257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/media\/9258"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/media?parent=9257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/categories?post=9257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/tags?post=9257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}